Scienture Announces 1-for-25 Reverse Split to Regain Nasdaq Compliance
SCNX is trading near its 52-week low of $0.238 (7.6% below the low) on light trading volume (0.1× avg).
Summary
Scienture Holdings will execute a 1-for-25 reverse stock split effective before market open on October 5, 2026, reducing shares outstanding from 41.06 million to approximately 1.64 million. The move is aimed at lifting the stock price above Nasdaq's $1 minimum bid requirement, as shares currently trade near $0.22. The reverse split will not change the ticker symbol but will assign a new CUSIP, and fractional shares will be settled in cash. While the split itself is a mechanical adjustment, it signals ongoing compliance pressure and may increase volatility due to the reduced float. The company recently launched REZENOPY and reported modest Q2 revenue, but the low share price reflects persistent market skepticism. Investors should watch whether the post-split price holds above $1 and whether upcoming product milestones or financing events provide fundamental support.
At the time of this announcement, SCNX was trading at $0.22 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $10.7M. The 52-week trading range was $0.24 to $2.60. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Wiseek News.